LAIKO MEDIS - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 41,868 | 40,204 | 34,397 | 39,681 | 42,018 | 32,875 | 20,392 | 17,054 |
| Profit before tax | 5,678 | 6,040 | 10,314 | 5,671 | 4,263 | -2,153 | 665 | 1,718 |
| Net profit | 5,394 | 5,738 | 9,798 | 5,387 | 4,050 | -2,153 | 623 | 1,611 |
| Equity | 36,952 | 42,690 | 52,488 | 57,875 | 61,925 | 41,344 | 41,967 | 43,578 |
| Liabilities | 16,209 | 0 | 0 | 0 | 0 | 0 | 0 | 2,133 |
| Non-current assets | 14,736 | 11,507 | 9,378 | 8,345 | 4,365 | 1,773 | 1,472 | 1,164 |
| Current assets | 38,425 | 31,183 | 43,110 | 49,530 | 57,560 | 39,268 | 10,495 | 44,547 |
| Total assets | 53,161 | 42,690 | 52,488 | 57,875 | 61,925 | 41,041 | 11,967 | 45,711 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 6,667 | 5,966 | 4,611 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +12.3% | -4.0% | -14.4% | +15.4% | +5.9% | -21.8% | -38.0% | -16.4% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 10.1% | 13.4% | 18.7% | 9.3% | 6.5% | -5.2% | 5.2% | 3.5% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 14.6% | 13.4% | 18.7% | 9.3% | 6.5% | -5.2% | 1.5% | 3.7% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 12.9% | 14.3% | 28.5% | 13.6% | 9.6% | -6.5% | 3.1% | 9.4% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 13.6% | 15.0% | 30.0% | 14.3% | 10.1% | -6.5% | 3.3% | 10.1% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.4 | - | - | - | - | - | - | 0.0 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 12,561 | 12,061 | 10,319 | 13,227 | 14,006 | 13,150 | 10,196 | 8,527 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
LAIKO MEDIS - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2024-03-18 | 2024-04-01 | 16.47 |
| 2023-12-18 | 2024-01-11 | 2.69 |
| 2023-11-16 | 2023-12-13 | 2.70 |
| 2023-10-25 | 2023-11-13 | 2.71 |
| 2023-08-17 | 2023-08-28 | 340.24 |
| 2023-07-28 | 2023-08-13 | 179.45 |
| 2023-07-26 | 2023-07-27 | 178.66 |
| 2023-07-24 | 2023-07-25 | 179.48 |
| 2023-07-18 | 2023-07-23 | 178.66 |
| 2023-06-16 | 2023-06-29 | 179.25 |
| 2023-05-16 | 2023-06-13 | 0.59 |
| 2023-05-02 | 2023-05-11 | 0.60 |
| 2023-04-26 | 2023-04-28 | 0.60 |
| 2023-04-18 | 2023-04-25 | 0.59 |
| 2023-03-16 | 2023-04-13 | 0.60 |
| 2023-02-17 | 2023-03-13 | 0.30 |
LAIKO MEDIS - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
LAIKO MEDIS, UAB (code 125919343) is a Private Limited Liability Company engaged in translation and interpretation activities. In the latest financial year, 2025, the company generated revenue of EUR 17.1K, down from EUR 20.4K in 2024 and EUR 32.9K in 2023, showing a continued contraction in turnover. At the same time, profitability improved materially: net profit was EUR 1.6K in 2025, compared with EUR 623 in 2024 and a net loss of EUR 2.2K in 2023. The 2025 profit margin reached 9.4%, supported by tighter cost control relative to sales. Balance sheet structure remained very solid, with equity of EUR 43.6K, total assets of EUR 45.7K and liabilities of EUR 2.1K at year-end 2025. The equity ratio stood at 95.3% and debt-to-equity at 0.05, indicating limited leverage. Asset turnover was 0.37x, reflecting a modest revenue base against the asset position. Revenue per employee was EUR 8.5K and profit per employee EUR 806 in 2025.